AI-generated summary
This review examines recent pharmaceutical strategies for preventing or treating radiation-induced oral mucositis in patients, especially those with head and neck cancer. The authors report that most tested drugs showed no effect or only limited effect, and that reliable data to guide clinical practice remain scarce. They also note that low-level laser therapy is effective but requires equipment and trained staff, so it is not widely used in routine care.
- Who or what was studied
- Patients with radiation-induced oral mucositis, particularly head and neck cancer patients
- Limits stated in the abstract
- The abstract states that there are still few reliable data to guide daily clinical practice and that most tested drugs showed no or limited effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.